THE EFFICACY OF RECOMBINANT ACTIVATED FACTOR VII (COAGIL VII) FOR TREATMENT HAEMORRHAGE AND HAEMOSTASIS DISORDES DURING THORACIC AORTA OPERATIONS
Goal: to evaluate the efficacy and safety of domestic (home-produced) recombinant factor VIIa (Coagil VII) for massive bleeding and haemostasis disordes treatment in thoracic aorta surgery. Methods. 82 patients undergoing surgery on thoracic aorta with cardiopulmonary bypass and circulatory arrest s...
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | Russian |
| Vydáno: |
New Terra Publishing House
2019-07-01
|
| Edice: | Вестник анестезиологии и реаниматологии |
| Témata: | |
| On-line přístup: | https://www.vair-journal.com/jour/article/view/333 |